[Retracted] Changes and Influencing Factors of Cognitive Impairment in Patients with Breast Cancer

Table 3

Ratio analysis of the current status of cognitive dimensions and subtests in patients with breast cancer chemotherapy (n = 172,%).

Subtests/dimensions	Result	Frequency	Percentage (%)	Cumulative percentage (%)
MCCB	Abnormal	114	66.28	66.28
	Normal	40	23.26	89.54
	Extraordinary	18	10.46	100.00
	In total	172	100.00
Working memory	Abnormal	126	73.26	73.26
	Normal	44	25.58	98.84
	Extraordinary	2	1.16	100.00
	In total	172	100.00
Attention/alertness	Abnormal	121	70.35	70.35
	Normal	43	25.00	95.35
	Extraordinary	8	4.65	100.00
	In total	172	100.00
Social cognition	Abnormal	112	65.12	65.12
	Normal	55	31.98	97.10
	Extraordinary	5	2.90	100.00
	In total	172	100.00
Visual memory	Abnormal	106	61.63	61.63
	Normal	50	29.07	90.70
	Extraordinary	16	9.30	100.00
	In total	172	100.00
Verbal memory	Abnormal	59	34.30	34.30
	Normal	90	52.33	86.63
	Extraordinary	23	13.37	100.00
	In total	172	100.00
Processing speed	Abnormal	47	27.33	27.33
	Normal	81	47.09	74.42
	Extraordinary	44	25.58	100.00
	In total	172	100.00
Reasoning and problem-solving	Abnormal	40	23.26	23.26
	Normal	86	50.00	73.26
	Extraordinary	46	26.74	100.00
	In total	172	100.00
Trail making test	Abnormal	45	26.16	26.16
	Normal	55	31.98	58.14
	Extraordinary	72	41.86	100.00
	In total	172	100.00
Symbolic coding test	Abnormal	136	79.07	79.07
	Normal	30	17.44	96.51
	Extraordinary	6	3.49	100.00
	In total	172	100.00
Category fluency test	Abnormal	23	13.37	13.37
	Normal	40	23.26	36.63
	Extraordinary	109	63.37	100.00
	In total	172	100.00
Number sequence test	Abnormal	57	33.14	33.14
	Normal	93	54.07	87.21
	Extraordinary	22	12.79	100.00
	In total	172	100.00
Spatial span test	Abnormal	139	80.81	80.81
	Normal	32	18.60	99.41
	Extraordinary	1	0.59	100.00
	In total	172	100.00